AneuploïdieL’aneuploïdie caractérise une cellule qui ne possède pas le nombre normal de chromosomes. Plus spécifiquement, cette anomalie chromosomique est caractérisée par un nombre de chromosomes qui n’est pas un multiple du nombre haploïde (nombre normal d’un seul jeu complet de chromosomes). Cette anomalie génétique est une mutation qui peut être viable ou non. Elle l’est généralement chez les plantes ou chez les champignons, lesquels présentent cette macromutation considérée comme une stratégie d’adaptation à des stress génotoxiques, rarement chez les mammifères (la recherche d’une aneuploïdie fœtale peut faire partie du dépistage prénatal).
Stem-cell lineA stem cell line is a group of stem cells that is cultured in vitro and can be propagated indefinitely. Stem cell lines are derived from either animal or human tissues and come from one of three sources: embryonic stem cells, adult stem cells, or induced stem cells. They are commonly used in research and regenerative medicine. Stem cell By definition, stem cells possess two properties: (1) they can self-renew, which means that they can divide indefinitely while remaining in an undifferentiated state; and (2) they are pluripotent or multipotent, which means that they can differentiate to form specialized cell types.
Host cell proteinHost cell proteins (HCPs) are process-related protein impurities that are produced by the host organism during biotherapeutic manufacturing and production. During the purification process, a majority of produced HCPs are removed from the final product (>99% of impurities removed). However, residual HCPs still remain in the final distributed pharmaceutical drug. Examples of HCPs that may remain in the desired pharmaceutical product include: monoclonal antibodies (mAbs), antibody-drug-conjugates (ADCs), therapeutic proteins, vaccines, and other protein-based biopharmaceuticals.
